Testosterone is the major androgen in circulation in male humans, produced primarily in the Leydig cells of the testis. Biosynthesis of testosterone from cholesterol occurs via a series of enzymatic reactions. Testosterone may be further metabolized into a more potent androgen, dihydrotestosterone. In recent years an alternate pathway of dihydrotestosterone biosynthesis without using testosterone as a precursor has emerged. Majority of classically studied effects of androgens are thought to be mediated via nuclear receptor-dependent long-term transcriptional effects, but there also exist membrane receptor-based effects of androgens which are being uncovered from recent studies that may explain rapid effects of androgens in many cases. In this chapter we are describing the biosynthesis, mechanism of action, and therapeutic effects of testosterone and related androgens.
- Anabolic steroids
- Androgen receptor
This is a preview of subscription content, access via your institution.
Auchus RJ. The backdoor pathway to dihydrotestosterone. Trends Endoscrinol Metab. 2004;15:432–8.
Biason-Lauber A, Miller WL, et al. Of marsupials and men: "backdoor" dihydrotestosterone synthesis in male sexual differentiation. Mol Cell Endocrinol. 2013;371(1–2):124–32.
Bongiovanni AM. The adrenogenital syndrome with deficiency of 3 beta-hydroxysteroid dehydrogenase. J Clin Invest. 1962;41:2086–92.
Bose HS, Sugawara T, et al. The pathophysiology and genetics of congenital lipoid adrenal hyperplasia. N Engl J Med. 1996;335(25):1870–8.
Burckhardt MA, Udhane S, et al. Human 3beta-hydroxysteroid-dehydrogenase deficiency seems to affect fertility but may not harbor a tumor risk: lesson from an experiment of nature. Eur J Endocrinol. 2015;173(5):K1–K12.
Burkhard FZ, Parween S, et al. P450 oxidoreductase deficiency: analysis of mutations and polymorphisms. J Steroid Biochem Mol Biol. 2017;165(Pt A):38–50.
Camats N, Pandey AV, et al. Ten novel mutations in the NR5A1 gene cause disordered sex development in 46,XY and ovarian insufficiency in 46,XX individuals. J Clin Endocrinol Metab. 2012;97(7):E1294–306.
de Castro AL, Cavalari FC, et al. Epitestosterone and testosterone have similar nonclassical actions on membrane of Sertoli cells in whole seminiferous tubules. Horm Metab Res. 2013;45(01):15–21.
Cavalari FC, de Castro AL, et al. Non-classic androgen actions in JSertoli cell membrane in whole seminiferous tubules: effects of nandrolone decanoate and catechin. Steroids. 2012;77(1–2):118–25.
Chang KH, Li R, et al. Dihydrotestosterone synthesis bypasses testosterone to drive castration-resistant prostate cancer. Proc Natl Acad Sci USA. 2011;108(33):13728–33.
Choi MH, Skipper PL, et al. Characterization of testosterone 11β-hydroxylation catalyzed by human liver microsomal cytochromes p450. Drug Metab Dispos. 2005;33(6):714–8.
Davey RA, Grossmann M. Androgen receptor structure, function and biology: from bench to bedside. Clin Biochem Rev. 2016;37(1):3–15.
Dhayat NA, Frey AC, et al. Estimation of reference curves for the urinary steroid metabolome in the first year of life in healthy children: tracing the complexity of human postnatal steroidogenesis. J Steroid Biochem Mol Biol. 2015;154:226–36.
Dhayat NA, Dick B, et al. Androgen biosynthesis during minipuberty favors the backdoor pathway over the classic pathway: insights into enzyme activities and steroid fluxes in healthy infants during the first year of life from the urinary steroid metabolome. J Steroid Biochem Mol Biol. 2017;165:312–322.
Duggal R, Liu Y, et al. Evidence that cytochrome b5 acts as a redox donor in CYP17A1 mediated androgen synthesis. Biochem Biophys Res Commun. 2016;477(2):202–8.
Faisal Ahmed S, Iqbal A, et al. The testosterone:androstenedione ratio in male undermasculinization. Clin Endocrinol. 2000;53(6):697–702.
Fassnacht M, Schlenz N, et al. Beyond adrenal and ovarian androgen generation: increased peripheral 5 alpha-reductase activity in women with polycystic ovary syndrome. J Clin Endocrinol Metab. 2003;88(6):2760–6.
Fevold HR, Lorence MC, et al. Rat P450(17 alpha) from testis: characterization of a full-length cDNA encoding a unique steroid hydroxylase capable of catalyzing both delta 4- and delta 5-steroid-17,20-lyase reactions. Mol Endocrinol. 1989;3(6):968–75.
Flück CE, Pandey AV. Impact on CYP19A1 activity by mutations in NADPH cytochrome P450 oxidoreductase. J Steroid Biochem Mol Biol. 2017;165(Pt A):64–70.
Flück CE, Miller WL, et al. The 17, 20-lyase activity of cytochrome P450c17 from human fetal testis favors the Δ5 steroidogenic pathway. J Clin Endocrinol Metab. 2003;88(8):3762–6.
Flück CE, Tajima T, et al. Mutant P450 oxidoreductase causes disordered steroidogenesis with and without Antley-Bixler syndrome. Nat Genet. 2004;36(3):228–30.
Flück CE, Meyer-Boni M, et al. Why boys will be boys: two pathways of fetal testicular androgen biosynthesis are needed for male sexual differentiation. Am J Hum Genet. 2011;89:201–18.
Flück CE, Pandey AV, et al. Characterization of novel StAR (steroidogenic acute regulatory protein) mutations causing non-classic lipoid adrenal hyperplasia. PLoS One. 2011;6(5):e20178.
Foradori CD, Weiser MJ, et al. Non-genomic actions of androgens. Front Neuroendocrinol. 2008;29(2):169–81.
Fukami M, Homma K, et al. Backdoor pathway for dihydrotestosterone biosynthesis: implications for normal and abnormal human sex development. Dev Dyn. 2013;242(4):320–9.
Govindan MV. Specific region in hormone binding domain is essential for hormone binding and trans-activation by human androgen receptor. Mol Endocrinol. 1990;4(3):417–27.
Hatzoglou A, Kampa M, et al. Membrane androgen receptor activation induces apoptotic regression of human prostate cancer cells in vitro and in vivo. J Clin Endocrinol Metab. 2005;90(2):893–903.
Hershkovitz E, Parvari R, et al. Homozygous mutation G539R in the gene for P450 oxidoreductase in a family previously diagnosed as having 17,20-lyase deficiency. J Clin Endocrinol Metab. 2008;93(9):3584–8.
Homma K, Hasegawa T, et al. Urine steroid hormone profile analysis in cytochrome P450 oxidoreductase deficiency: implication for the backdoor pathway to dihydrotestosterone. J Clin Endocrinol Metab. 2006;91(7):2643–9.
Idkowiak J, Randell T, et al. A missense mutation in the human cytochrome b5 gene causes 46,XY disorder of sex development due to true isolated 17,20 lyase deficiency. J Clin Endocrinol Metab. 2012;97(3):E465–75.
Ishii Y, Nurrochmad A, et al. Modulation of UDP-glucuronosyltransferase activity by endogenous compounds. Drug Metab Pharmacokinet. 2010;25(2):134–48.
Ishii Y, Koba H, et al. Alteration of the function of the UDP-glucuronosyltransferase 1A subfamily by cytochrome P450 3A4: different susceptibility for UGT isoforms and UGT1A1/7 variants. Drug Metab Dispos. 2014;42(2):229–38.
Kamrath C, Hochberg Z, et al. Increased activation of the alternative "backdoor" pathway in patients with 21-hydroxylase deficiency: evidence from urinary steroid hormone analysis. J Clin Endocrinol Metab. 2012;97(3):E367–75.
Ko E, Choi H, et al. Testosterone stimulates Duox1 activity through GPRC6A in skin keratinocytes. J Biol Chem. 2014;289(42):28835–45.
Kuiri-Hanninen T, Sankilampi U, et al. Activation of the hypothalamic-pituitary-gonadal axis in infancy: minipuberty. Hormone research in paediatrics. 2014;82(2):73–80.
Lieberherr M, Grosse B. Androgens increase intracellular calcium concentration and inositol 1,4,5-trisphosphate and diacylglycerol formation via a pertussis toxin-sensitive G-protein. J Biol Chem. 1994;269(10):7217–23.
Loss ES, Jacobsen M, et al. Testosterone modulates K+ATP channels in Sertoli cell membrane via the PLC-PIP2 pathway. Horm Metab Res. 2004;36(08):519–25.
Lourenco D, Brauner R, et al. Loss-of-function mutation in GATA4 causes anomalies of human testicular development. Proc Natl Acad Sci USA. 2011;108(4):1597–602.
Marti N, Galvan JA, et al. Genes and proteins of the alternative steroid backdoor pathway for dihydrotestosterone synthesis are expressed in the human ovary and seem enhanced in the polycystic ovary syndrome. Mol Cell Endocrinol. 2016;441:116–23.
Matsumoto T, Sakari M, et al. The androgen receptor in health and disease. Annu Rev Physiol. 2013;75(1):201–24.
Miller WL. The syndrome of 17,20 lyase deficiency. J Clin Endocrinol Metab. 2012;97(1):59–67.
Miller WL, Auchus RJ. The molecular biology, biochemistry, and physiology of human steroidogenesis and its disorders. Endocr Rev. 2011;32(1):81–151.
Miller WL, Flück CE. Adrenal cortex and its disorders. In: Sperling MA, editor. Pediatric endocrinology. Philadelphia: Saunders; 2014.
Neunzig J, Sánchez-Guijo A, et al. A steroidogenic pathway for sulfonated steroids: the metabolism of pregnenolone sulfate. J Steroid Biochem Mol Biol. 2014;144(Part B):324–33.
Nicolo C, Flück CE, et al. Restoration of mutant cytochrome P450 reductase activity by external flavin. Mol Cell Endocrinol. 2010;321(2):245–52.
Pandey AV, Flück CE. NADPH P450 oxidoreductase: structure, function, and pathology of diseases. Pharmacol Ther. 2013;138(2):229–54.
Pandey AV, Sproll P. Pharmacogenomics of human P450 oxidoreductase. Front Pharmacol. 2014;5:103.
Pandey AV, Kempna P, et al. Modulation of human CYP19A1 activity by mutant NADPH P450 oxidoreductase. Mol Endocrinol. 2007;21(10):2579–95.
Papakonstanti EA, Kampa M, et al. A rapid, nongenomic, signaling pathway regulates the actin reorganization induced by activation of membrane testosterone receptors. Mol Endocrinol. 2003;17(5):870–81.
Parween S, Roucher-Boulez F, et al. P450 oxidoreductase deficiency: loss of activity caused by protein instability from a novel L374H mutation. J Clin Endocrinol Metab. 2016;101(12):4789–98.
Peterson RE, Imperato-McGinley J, et al. Male pseudohermaphroditism due to multiple defects in steroid-biosynthetic microsomal mixed-function oxidases. A new variant of congenital adrenal hyperplasia. N Engl J Med. 1985;313(19):1182–91.
Pi M, Parrill AL, et al. GPRC6A mediates the non-genomic effects of steroids. J Biol Chem. 2010;285(51):39953–64.
Prader A, Gurtner HP. The syndrome of male pseudohermaphrodism in congenital adrenocortical hyperplasia without overproduction of androgens (adrenal male pseudohermaphrodism). Helv Paediatr Acta. 1955;10(4):397–412.
Simoncini T, Genazzani A. Non-genomic actions of sex steroid hormones. Eur J Endocrinol. 2003;148(3):281–92.
Strott CA. Steroid sulfotransferases. Endocr Rev. 1996;17(6):670–97.
Suntharalingham JP, Buonocore F, et al. DAX-1 (NR0B1) and steroidogenic factor-1 (SF-1, NR5A1) in human disease. Best Pract Res Clin Endocrinol Metab. 2015;29(4):607–19.
Swart AC, Storbeck KH. 11beta-Hydroxyandrostenedione: downstream metabolism by 11betaHSD, 17betaHSD and SRD5A produces novel substrates in familiar pathways. Mol Cell Endocrinol. 2015;408:114–23.
Ueda T, Mawji NR, et al. Ligand-independent activation of the androgen receptor by Interleukin-6 and the role of steroid receptor coactivator-1 in prostate cancer cells. J Biol Chem. 2002;277(41):38087–94.
Walker WH. Non-classical actions of testosterone and spermatogenesis. Philos Trans R Soc B: Biol Sci. 2010;365(1546):1557–69.
Wang C, Liu Y, et al. G protein-coupled receptors: extranuclear mediators for the non-genomic actions of steroids. Int J Mol Sci. 2014;15(9):15412.
van de Wijngaart DJ, Dubbink HJ, et al. Androgen receptor coregulators: recruitment via the coactivator binding groove. Mol Cell Endocrinol. 2012;352(1–2):57–69.
Zachmann M. Prismatic cases: 17,20-desmolase (17,20-lyase) deficiency. J Clin Endocrinol Metab. 1996;81(2):457–9.
This work has been supported by the Swiss National Science Foundation grant 320030-146127.
Editors and Affiliations
© 2017 Springer International Publishing AG
About this entry
Cite this entry
Flück, C.E., Pandey, A.V. (2017). Testicular Steroidogenesis. In: Simoni, M., Huhtaniemi, I. (eds) Endocrinology of the Testis and Male Reproduction. Endocrinology. Springer, Cham. https://doi.org/10.1007/978-3-319-29456-8_10-1
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-29456-8
Online ISBN: 978-3-319-29456-8
eBook Packages: Springer Reference MedicineReference Module Medicine